FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vahe Bedian

Research Profile

Living Beings

Chemicals & Drugs

Physiology

Procedures

Co-author Network

Publications

TOP 3
Naomi Laing; Deborah Lawson; Brenda McDermott; Corinne Reimer; Michael Snaith; Xin Wang; Shenghua Wen; David Yang; Harriet Andersén; Vahe Bedian; Zhu A Cao; Mike Collins; Peter A Hall; David Blakey
Inhibition of Platelet-Derived Growth Factor Receptor α by MEDI-575 Reduces Tumor Growth and Stromal Fibroblast Content in a Model of Non-Small Cell Lung Cancer.
David W Jenkins; Jane Kendrew; Kathy Manchulenko; Li Peng; Philip Petteruti; Sarah Ross; Neil R Smith; Margaret Veldman-Jones; Hazel M Weir; Vahe Bedian; David C Blakey; Song Cho; Brandon C Clavette; Melissa Damschroder; Cath Eberlein; Ian N Foltz; Dawn Baker; Simon T Barry
MEDI0639: a novel therapeutic antibody targeting Dll4 modulates endothelial cell function and angiogenesis in vivo.
Ronald P Gladue; Ed Natoli; Robin Nelson; Timothy J Paradis; Richard Shepard; Susan H Cole; Carol Donovan; Eileen Elliott; Joe Gardner; Robbin Alpert; Vahe Bedian
The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vahe Bedian (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Naomi Laing; Deborah Lawson; Brenda McDermott; Corinne Reimer; Michael Snaith; Xin Wang; Shenghua Wen; David Yang; Harriet Andersén; Vahe Bedian; Zhu A Cao; Mike Collins; Peter A Hall; David Blakey
Inhibition of Platelet-Derived Growth Factor Receptor α by MEDI-575 Reduces Tumor Growth and Stromal Fibroblast Content in a Model of Non-Small Cell Lung Cancer.
Molecular pharmacology 2013;83(6):1247-56.
2012: David W Jenkins; Jane Kendrew; Kathy Manchulenko; Li Peng; Philip Petteruti; Sarah Ross; Neil R Smith; Margaret Veldman-Jones; Hazel M Weir; Vahe Bedian; David C Blakey; Song Cho; Brandon C Clavette; Melissa Damschroder; Cath Eberlein; Ian N Foltz; Dawn Baker; Simon T Barry
MEDI0639: a novel therapeutic antibody targeting Dll4 modulates endothelial cell function and angiogenesis in vivo.
Molecular cancer therapeutics 2012;11(8):1650-60.
2011: Ronald P Gladue; Ed Natoli; Robin Nelson; Timothy J Paradis; Richard Shepard; Susan H Cole; Carol Donovan; Eileen Elliott; Joe Gardner; Robbin Alpert; Vahe Bedian
The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice.
Cancer immunology, immunotherapy : CII 2011;60(7):1009-17.
2010: Jeffrey L Brown; Z Alexander Cao; Maria Pinzon-Ortiz; Jane Kendrew; Corinne Reimer; Shenghua Wen; Joe Q Zhou; Mohammad A Tabrizi; Steve Emery; Brenda McDermott; Lourdes Pablo; Patricia McCoon; Vahe Bedian; David C Blakey
A human monoclonal anti-ANG2 antibody leads to broad antitumor activity in combination with VEGF inhibitors and chemotherapy agents in preclinical models.
Molecular cancer therapeutics 2010;9(1):145-56.
2003: MichaeI Moxness; Jim Foley; Mark Stene; Deborah Finco-Kent; Vahe Bedian; Alan Krasner; Thomas Kawabata
Development and validation of radioligand binding assays to measure total, IgA, IgE, IgG, and IgM insulin antibodies in human serum.
Annals of the New York Academy of Sciences 2003;1005():265-8.
2003: Deborah Finco-Kent; A Morrone; M Moxness; Vahe Bedian; Alan Krasner; J Foley; M Stene; T Kawabata
Development and validation of a radioligand binding assay to measure insulin specific IgG subclass antibodies in human serum.
Annals of the New York Academy of Sciences 2003;1005():259-64.
2002: Sarah Wise; Norman T Davis; Elizabeth Tyndale; Jocelyne Noveral; Mary Grace Folwell; Vahe Bedian; Ivette F Emery; Kathleen K Siwicki
Neuroanatomical studies of period gene expression in the hawkmoth, Manduca sexta.
The Journal of comparative neurology 2002;447(4):366-80.
2002: Qian Zhang; Renold J Capocasale; Floyd E Fox; Vahe Bedian; Eric Vonderheid; Alain H Rook; Jonni S Moore; Peter C Nowell; Dale S Haines; Mariusz A Wasik
Diminished expression of the type II receptor for TGFbeta (TGFbetaRII) in T lymphocytes from patients with Sezary syndrome is not due to mutations in the receptor's poly-A tract: limitations of the standard RT-PCR in cDNA sequence analysis of homopolymeric base stretches.
Archivum immunologiae et therapiae experimentalis 2002;50(6):421-9.
1998: R B Hough; Andreas Lengeling; Vahe Bedian; Cecilia Lo; M Bućan
Rump white inversion in the mouse disrupts dipeptidyl aminopeptidase-like protein 6 and causes dysregulation of Kit expression.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(23):13800-5.
1997: Vahe Bedian; T Adams; E A Geiger; L Charles Bailey; David L Gasser
A gene belonging to the Sm family of snRNP core proteins maps within the mouse MHC.
Immunogenetics 1997;46(5):427-30.
1996: L Bi; R Sarkar; T Naas; Ann M Lawler; J Pain; S L Shumaker; Vahe Bedian; Haig Kazazian
Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies.
Blood 1996;88(9):3446-50.
1995: Ronald F Feinberg; H J Kliman; Vahe Bedian; Federico Monzon; A W Menzin; C L Wang
Monoclonal antibody X18A4 identifies an oncofetal fibronectin epitope distinct from the FDC-6 binding site.
American journal of obstetrics and gynecology 1995;172(5):1526-36.
1994: I F Emery; Vahe Bedian; Gregory M Guild
Differential expression of Broad-Complex transcription factors may forecast tissue-specific developmental fates during Drosophila metamorphosis.
Development (Cambridge, England) 1994;120(11):3275-87.
1994: NS Morrissette; Vahe Bedian; P Webster; David S Roos
Characterization of extreme apical antigens from Toxoplasma gondii.
Experimental parasitology 1994;79(3):445-59.